Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis
EstoniaStudy on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis
BulgariaStudy on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo
BulgariaPharmacokinetic Study of Ritlecitinib Tosilate in Healthy Adults: Oral Solution, Short‑and Long‑Duration Capsules Fed vs Fasted – for ulcerative colitis
BelgiumPhase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis
CzechiaJNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
GermanyCorabotase for Moderate to Severe Glabellar Lines in Adults
FranceA study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa
BulgariaA Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyA study to evaluate the effectiveness and safety of zasocitinib in patients with moderate to severe hidradenitis suppurativa
FranceEvaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster
DenmarkA study to evaluate the safety and effectiveness of BO-112 injections in patients with resectable primary basal cell carcinoma.
SpainThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
